Mangoceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $105 | $133 | $163 | $214 |
Gross Profit | 80 | 82 | 69 | 147 |
EBITDA | -1,677 | -1,758 | -2,165 | -2,361 |
EBIT | -2,399 | -1,758 | -2,168 | -2,367 |
Net Income | -1,948 | -1,999 | -2,390 | -2,367 |
Net Change In Cash | 105 | 133 | 163 | 214 |
Free Cash Flow | -1,129 | -1,165 | -1,577 | -991 |
Cash | 58 | 73 | 490 | 15 |
Basic Shares | 1,978 | 2,013 | 1,739 | 1,522 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $473 | $731 | $8 |
Gross Profit | 237 | 431 | 4 |
EBITDA | -7,962 | -9,187 | -1,987 |
EBIT | -8,693 | -9,212 | -1,991 |
Net Income | -8,706 | -9,212 | -1,998 |
Net Change In Cash | 473 | 731 | 8 |
Free Cash Flow | -4,863 | -7,000 | -1,389 |
Cash | 58 | 739 | 682 |
Basic Shares | 1,978 | 1,074 | 1,021 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.60 |
2024-09-30 | -$0.99 |
2024-06-30 | -$1.37 |
2024-03-31 | -$1.55 |
